Sanofi Genzyme

Sanofi Genzyme focuses on developing specialty treatments for debilitating diseases that are often difficult to diagnose and treat.

Sanofi Genzyme and Regeneron are committed to providing resources to advance research in dermatology in areas of unmet medical needs among patients with inadequately controlled moderate-to-severe atopic dermatitis.

We provide here a suite of tools that can be used to evaluate the disease severity and control of your patients with AD.

MAT-IE-2000962 (v2.0)
Date of Preparation: September 2020